Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2025-12-30 @ 2:14 AM
Study NCT ID:
NCT01315457
Status:
COMPLETED
Last Update Posted:
2012-05-24
First Post:
2011-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Infections Associated With the Use of Alemtuzumab
Sponsor:
Samsung Medical Center
Organization:
Study Overview
Official Title:
Asian Multinational Retrospective Analysis for Infectious Complications in Patients Treated With Alemtuzumab
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to propose infection prophylaxis from Asian multinational retrospective analysis of infectious complications in patients who were treated with alemtuzumab
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: